ResearcherTongji UniversityActive in the last 2 years

Yufei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6802-4346; OpenAlex author ID A5100411552. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. Co-author DOI 10.1186/s12885-024-12934-y ↗
Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT? Co-author DOI 10.1186/s40644-023-00528-z ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianping Lu · 2 shared papers, 2023–2024 · strength 0.39
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗
Chao Ma · 2 shared papers, 2023–2024 · strength 0.39
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗
Yun Bian · 2 shared papers, 2023–2024 · strength 0.39
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗
Panpan Yang · 2 shared papers, 2023–2024 · strength 0.39
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗
Chengwei Shao · 2 shared papers, 2023–2024 · strength 0.39
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗
Luguang Chen · 1 shared paper, 2024 · strength 0.21
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y ↗
Jun Wang · 1 shared paper, 2023 · strength 0.18
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.